You are here:- Conferences .. HepHIV2014 Conference .. Presentations .. PO4/PS5: The treatment cascade

PO4/PS5: The treatment cascade


PO4/01 Changes in the Epidemiology of Hepatitis C Virus Co-infection in Recent Years in the PISCIS HIV Cohort, 1998-2012

PO4/02 Prevalence, Risk Factors and Genotype Distribution of HCV Infection among Patients Living with HIV in North-easten Poland

PO4/03 Sexual Orientation and High Risk Behaviors Are Not Associated with Being Lost-to-Care after HIV Diagnosis: Data from Test and Keep in Care (TAK) Project

PO4/04 Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004-2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions

PO4/05 Treatment Outcome of HART-treated Patients in a Resource-limited Setting: The Belgrade Cohort Study

PO4/06 NGO-based Voluntary Counseling and Rapid Testing (VCRT) Improves Access to Testing and Linkage to Care by Key Populations in Kyrgyzstan

PO4/07 Treatment and Care in Resource Limitted Setings vs. High Income Settings

PO4/08 HIV Testing in an Acute Assessment Unit Is Feasible and Cost-effective

PO4/09 Vulnerability assessment of people living with HIV (PLHIV) in Lithuania

PO4/10 Gender Aspects of Situation with Diagnostics of Hepatitis among People Living with HIV in Pavlodar Region, Kazakhstan

PO4/11 HIV cascade of care in Luhansk region of Ukraine

PO4/12 Factor associated with HIV viral suppression in patients with HIV-HCV co-infection in Spain, 2004-2013

PS5/01 Continuum of Care of the Patients Diagnosed with HIV in Belgium According to Region of Origin

PS5/02 Peer education at infectious diseases units as a mechanism to optimize the left side steps of the HIV treatment cascade

PS5/03 Regional differences in hepatitis testing, vaccination and treatment in the EuroSIDA study

PS5/04 Exploring how Commonly Diagnosing Services Refer Newly Diagnosed Chronic Hepatitis B and C Patients to Specialist Secondary Care: The Views of Hepatologists, Gastroenterologists and Infectious Diseases Specialists in Six EU Countries

PS5/05 Evidence for the Cost-effectiveness of Screening for Chronic Hepatitis B and C among Migrant Populations: Results from a Review of the Literature
 New EU project
Friday, September 01, 2017

CHIP will be the coordinator for the new EU funded Joint Action INTEGRATE. The launch of INTEGRATE will happen in Brussels 19 September 2017 where the EU commissioner for Food and Health will participate.
Read more here

 Late presentation of chronic viral hepatitis for medical care: a consensus definition
Monday, May 08, 2017

New publication! Late presentation of chronic viral hepatitis for medical care: a consensus definition. Read the full article here.

 Two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL
Tuesday, April 04, 2017

Don't miss out! Join a two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL. The course takes place on 28 and 29 September 2017. Read more here.

 Evaluation of the HepHIV 2017 Conference
Monday, April 03, 2017

The evaluation report from the HepHIV conference is now available. You can access it here.

 The HIV in Europe 2016 Annual Report is now available!
Monday, April 03, 2017

You can now read about our 2016 projects, activities and achievements in our annual report. Find it here.

 New report: The HIV in Europe initiative - the first 10 years
Tuesday, January 31, 2017

2017 marks 10 years of HIV in Europe - read about the 10 years of working with different stakeholders to promote earlier testing and care in our new report

 HepHIV 2017 Malta Conference
Tuesday, January 31, 2017

HepHIV 2017 Conference is now taking place in Malta (31 January - 2 February 2017). See full programme here. You can also follow news and updates on Twitter by following the conference hashtag #HepHIV2017


Copyright 2009 by HIV in Europe